Neocortical and hippocampal TREM2 protein levels during the progression of Alzheimer’s disease

Heterozygous TREM2 mutations are an Alzheimer’s disease (AD) risk factor. Non-mutated TREM2 dysregulation occurs in AD brain. Whether TREM2 is altered in prodromal AD remains unknown. Western blotting was used to determine levels of TREM2 (~ 25 kDa) and Iba1 in the frontal cortex and TREM2 in the hi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neurobiol Aging
Asıl Yazarlar: Perez, Sylvia E., Nadeem, Muhammad, He, Bin, Miguel, Jennifer C., Malek-Ahmadi, Michael H., Chen, Kewei, Mufson, Elliott J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6344038/
https://ncbi.nlm.nih.gov/pubmed/28365005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neurobiolaging.2017.02.012
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller